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Abstract: 
Salivary, mammary and prostate glands are sex hormone-dependent organs sharing common aspects in structure, hormonal 
responsiveness and tumor histopathology. Salivary tumors (especially the malignant types) are not as frequent as mammary and 
prostate neoplasias.  Hence, prognosis of some salivary tumors is not always efficient. Here, we review the oncology of salivary 
gland and its putative relation to breast/prostate tumors.   
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Background: 
Salivary glands comprise a group of minor and major 
glands lining the oral cavity and they secrete saliva. Saliva 
is a complex fluid like plasma reflecting in organic 
constituents. It is of use for the diagnosis and prognosis of 
certain diseases. [1, 2] Salivary glands share similar 
characteristics (morphology, sex hormone dependency, 
cellular mechanisms, and tumor histopathology) to breast 
and prostate. [3-8] Mammary and prostate tumors are 
among the most frequent in women and in men, 
respectively. Salivary tumors correspond to only 3% of all 
the neoplasms depending on the geographical prevalence 
unlike frequently seen mammary and prostrate cancers. [9] 
Malignant salivary tumors are infrequent and a good 
prognosis is not always available. Here, we review the 
association of salivary tumors with mammary and prostate 
neoplasias. 
 
Relating salivary tumors with breast and prostate 
neoplasias: 
Some authors showed that salivary gland tumors may be 
associated with other neoplasias, mainly breast and prostate 
tumors. This is especially referred to the increased number 
of second primary tumors. [3,7] Evidences, although 
scarce, are discussed below.  
 
Second primary tumors: 
In humans, salivary glands are an elective site for second 
primary tumors of breast and prostate neoplasias. [3,4] 
Thus, it was shown that women bearing a first primary 
salivary tumor (benign or malignant) have 4-5 fold 
increased risk of a second primary tumor in breast. [5] In 
coincidence with this finding, it was observed that rarely 
found multiple tumors (each one with identical or different 
histology) of the salivary glands appear simultaneously 
with extra-glandular tumors, especially breast carcinomas. 
[10] This fact would indicate an association between 
hormone dependent cancers, implying alertness in the 
follow-up of those patients. [3, 4] 
 
 
 
Metastatic tumors: 
Metastatic breast and prostate cancer dissemination also 
affects the parotid and submandibular glands. [11, 12, 13, 
14]  
 
Experimental evidence: 
There are experimental evidences pointing to the 
association between salivary and mammary tumorigenesis. 
For instance, occasional salivary tumors were seen in a 
model of mammary tumors (transgenic TG.SH mice: 
mouse mammary tumor virus/v-Ha-ras). [15]  
 
Analogy with tumor histopathologic types: 
Salivary, mammary and prostate glands share very similar 
histopathologic types of benign and malignant tumors. For 
example, pleomorphic adenomas and mucocele-like tumors 
of human breast are analogous in histology to the same 
entities of salivary glands. [16,17] Other tumors like 
adenomyoepitheliomas, acinic cell-like, mucoepidermoid 
carcinomas and salivary duct carcinoma of the breast are 
shown to be the counterpart of those of the salivary glands. 
[18, 19, 20, 21] In addition, salivary duct carcinoma is 
histologically similar to that of prostatic origin. [21] 
 
Influence of sex hormones: 
Like normal glands, neoplastic salivary glands are also 
hormone-dependent with increased steroid metabolism. 
[22, 23] Molteni et al., and Ozono et al., detected estradiol 
(E2) in salivary tumors (including benign pleomorphic 
adenomas). [24, 25] On the contrary, Gaffney et al., did not 
find estrogen receptor neither in benign nor in malignant 
parotid tumors. However, they detected E2 in breast cancer 
sections, being uncertain about its role in parotid tumor 
growth regulation. [26] The parotid gland contains steroid 
metabolizing enzymes which favor an oxidative reaction 
pathway, and the 17 beta-HSDH activity is significantly 
elevated in human neoplastic tissue. [23]   
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therapeutic value. [25, 27] Testosterone and dihydro-
testosterone associated with prostate tumors are negatively 
immunostained in human pleomorphic adenomas. [28, 29] 
Testosterone did not promote the development of 
carcinomas in DMBA-injected submandibular gland of 
murine. However, it increased the secretion of salivary 
epidermal growth factor (EGF), a tumor-enhancing factor 
in mammary cancer. [30]  
 
Polyoma virus inoculation appeared to induce salivary 
tumors in 70% and 30% of male and female mice, 
respectively. Testosterone treatment increased the tumor 
frequency in 69-90% of male mice. Nonetheless, 
orchidectomy (surgical removal of testicles) reduced it to 
50%. Oophorectomy (surgical removal of ovaries) as well 
as estrogen treatment had no effect on salivary gland tumor 
frequency in females. However, estrogen treatment was 
associated with breast second primary tumors in 60% of 
female animals bearing salivary gland tumors. [31]  
Conclusion: 
Tumors of salivary glands share very similar 
histopathological characteristics with breast and prostate 
neoplasias. They are also influenced by sex hormones. In 
addition, salivary glands seem to be an elective site for 
second primary tumors and metastatic lesions of breast and 
prostate, proposing that these neoplasias are associated with 
each other in tumorigenesis. Since the mechanism is not 
known, information leading to association will help in the 
diagnosis and prognosis of these related cancers. 
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